Item 2. Properties
Item 2. Properties
Our principal executive offices are located in South San Francisco, California. We entered into the lease for our principal executive offices in August 2022, for approximately 55,000 square feet of combined office and laboratory space in South San Franscisco, which will expire in August 2033. In December 2024, we entered into a lease for approximately 22,000 square feet of additional office space in South San Francisco, California which will end in December 2026.
Upon the closing of the ACELYRIN Merger, the Company became the successor to ACELYRIN’s rights under ACELYRIN’s lease agreements that included approximately 10,012 square feet of office space in Southern California, which expires in August 2028, and approximately 22,365 square feet of office space in South San Francisco, California, which expires in October 2029. Both facilities have been subleased through the end of their lease terms.
We believe our facilities are adequate and suitable for our current needs, and that should it be needed, suitable additional or alternative space will be available to accommodate our operations.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.